Similar articles

• High-dose-rate versus low-dose-rate monotherapy in the treatment of localized prostate cancer. The case for high-dose-rate monotherapy: An up and coming treatment option for low-risk prostate cancer.

  Sylvester JE. Sylvester JE. Brachytherapy. 2006 Jan-Mar;5(1):1-4; discussion 7. doi: 10.1016/j.brachy.2006.01.001. Brachytherapy. 2006. PMID: 16563988 Review. No abstract available.
• High-dose-rate versus low-dose-rate monotherapy in the treatment of localized prostate cancer: The case for low-dose-rate monotherapy.

  Stock RG. Stock RG. Brachytherapy. 2006 Jan-Mar;5(1):5-6; discussion 8. doi: 10.1016/j.brachy.2006.01.003. Brachytherapy. 2006. PMID: 16563989 No abstract available.
• A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.

  Ali I, Algan O, Thompson S, Sindhwani P, Herman T, Cheng CY, Ahmad S. Ali I, et al. Phys Med Biol. 2009 Sep 21;54(18):5595-611. doi: 10.1088/0031-9155/54/18/016. Epub 2009 Aug 28. Phys Med Biol. 2009. PMID: 19717887 Clinical Trial.
• Low-dose-rate brachytherapy for prostate cancer: preplanning vs. intraoperative planning-preplanning is best.

  Blasko JC. Blasko JC. Brachytherapy. 2006 Jul-Sep;5(3):139-42; discussion 145. doi: 10.1016/j.brachy.2006.04.004. Brachytherapy. 2006. PMID: 16864061 Review. No abstract available.
• Options and recent advances in permanent brachytherapy for prostate cancer.

  Marshall DT. Marshall DT. Can J Urol. 2007 Dec;14 Suppl 1:28-31. Can J Urol. 2007. PMID: 18163942 Review.